Standout Papers

Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, mul... 2005 2026 2012 2019 816
  1. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial (2005)
    Kristian Reich, Frank O. Nestlé et al. The Lancet

Immediate Impact

3 by Nobel laureates 29 from Science/Nature 80 standout
Sub-graph 1 of 18

Citing Papers

GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
Active biointegrated living electronics for managing inflammation
2024 StandoutScience
2 intermediate papers

Works of Robert J. Evans being referenced

Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial
2005 Standout
Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial
2004

Author Peers

Author Last Decade Papers Cites
Robert J. Evans 878 961 589 1800 1067 90 3.7k
Gerald G. Krueger 103 878 672 3427 2227 113 5.8k
Jan Dutz 114 1610 600 2988 926 155 5.9k
Hsien‐Ching Chiu 171 418 358 665 952 113 3.0k
Anna Campanati 78 456 391 1205 977 180 3.1k
Kamran Ghoreschi 134 1255 578 4266 1654 139 7.9k
Naoko Kanda 75 659 409 1599 1344 153 4.1k
Mamitaro Ohtsuki 83 803 445 3614 3274 183 6.5k
J.‐P. Ortonne 37 545 343 1974 1479 69 3.3k
J.L. Burton 292 425 679 236 1515 140 3.8k
Reinhart Speeckaert 66 259 310 1260 727 142 3.9k

All Works

Loading papers...

Rankless by CCL
2026